Relmada Therapeutics
RLMD
#7932
Rank
โ‚ฌ0.26 B
Marketcap
3,56ย โ‚ฌ
Share price
-5.20%
Change (1 day)
793.91%
Change (1 year)

Market capitalization of Relmada Therapeutics (RLMD)

Market cap: โ‚ฌ0.26 Billion

As of December 2025 Relmada Therapeutics has a market cap of โ‚ฌ0.26 Billion. This makes Relmada Therapeutics the world's 7932th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Relmada Therapeutics from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ0.26 B2253.69%
2024โ‚ฌ11.1 M-90.15%
2023โ‚ฌ0.11 B15.11%
2022โ‚ฌ97.92 M-82.25%
2021โ‚ฌ0.55 B29.59%
2020โ‚ฌ0.42 B-15.39%
2019โ‚ฌ0.50 B1582.16%
2018โ‚ฌ29.92 M281.6%
2017โ‚ฌ7.84 M-37.13%
2016โ‚ฌ12.47 M-54.54%
2015โ‚ฌ27.43 M-79.95%
2014โ‚ฌ0.13 B

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of Relmada Therapeutics was reported to be:

โ‚ฌ0.27 Billion
by Nasdaq info icon info icon
โ‚ฌ0.27 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Taro Pharmaceutical
TARO
โ‚ฌ1.37 B 425.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cytokinetics
CYTK
โ‚ฌ6.32 B 2,318.10%๐Ÿ‡บ๐Ÿ‡ธ USA